| Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||
Net income | |||||||||
52,059 | 42,894 | 49,144 | 52,295 | 46,902 | 41,059 | 39,544 | 31,650 | 28,507 | 8,364 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||
ESOP and stock-based compensation expense | |||||||||
3,152 | 3,682 | 5,144 | 10,387 | 8,764 | 8,992 | 9,028 | 7,180 | 1,705 | 12,392 |
Amount of cash inflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments resulting from a tax deficiency associated with the compensation cost recognized for financial reporting purposes. | |||||||||
261 | 1,122 | 1,430 | - | - | - | - | - | - | - |
Depreciation of premises and equipment | |||||||||
735 | 810 | 864 | - | - | - | - | - | - | - |
Tax benefit from stock-based compensation | |||||||||
- | - | - | -2,118 | -1,217 | 894 | - | - | - | - |
Depreciation of premises and equipment | |||||||||
- | - | - | 910 | 935 | 957 | 975 | 930 | 856 | 815 |
Net amortization and accretion of premiums and discounts on securities | |||||||||
-1,143 | -1,170 | -1,322 | -1,145 | -1,232 | -1,230 | -2,195 | -2,392 | -850 | 155 |
Reversal of provision for loan losses | |||||||||
-2,000 | 0 | 0 | 0 | 200 | 700 | 3,850 | 8,500 | 9,300 | 10,000 |
Amortization and accretion of deferred loan fees, net | |||||||||
2,542 | 2,692 | 2,262 | 3,371 | 3,768 | 3,034 | 2,820 | 1,599 | 1,076 | 913 |
Decrease in deferred taxes | |||||||||
1,403 | -8,763 | 982 | -229 | 3,707 | 2,871 | 5,098 | 3,969 | -213 | 3,337 |
Profit on sale of loans | |||||||||
- | - | - | - | - | -58 | 72 | 580 | 0 | - |
Impairment charge on securities | |||||||||
- | - | - | - | - | - | - | 262 | 291 | - |
Impairment charge on securities | |||||||||
- | - | - | - | - | - | - | - | - | 202 |
Net losses on sale of debt securities available for sale | |||||||||
0 | -324 | -826 | - | - | - | - | - | - | - |
Change in fair value of equity securities | |||||||||
-208 | 0 | 0 | - | - | - | - | - | - | - |
Loss (gain) on sale of securities | |||||||||
- | - | - | 990 | 768 | 51 | 0 | 0 | 242 | 35 |
Gain (loss), before tax, on sale of real estate investments and real estate joint ventures | |||||||||
0 | 0 | 20,856 | 37,544 | 11,616 | 0 | 0 | - | - | - |
Derivatives termination cost, net | |||||||||
0 | 0 | -7,670 | 0 | 0 | - | - | - | - | - |
Gain on sale of other assets | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Gain on sale of real estate held for investment | |||||||||
- | - | - | - | - | - | - | - | - | 1,043 |
(Gain) on sale of real estate owned | |||||||||
855 | -2 | 0 | 328 | -9 | 221 | 631 | 210 | 718 | - |
Writedown of real estate owned | |||||||||
79 | 0 | 215 | 250 | 1,430 | 196 | 150 | - | - | - |
Increases in the value of the cash surrender value of bank owned life insurance policies. | |||||||||
2,434 | 2,492 | 2,618 | 2,718 | 2,555 | 2,018 | 1,781 | - | - | - |
Increase in cash surrender value of bank owned life insurance | |||||||||
- | - | - | - | - | - | - | - | - | 1,144 |
Increase in cash surrender value of bank owned life insurance | |||||||||
- | - | - | - | - | - | - | -1,594 | -1,210 | - |
Increase in accrued interest receivable | |||||||||
674 | 641 | 677 | 677 | -948 | 100 | -516 | 1,393 | -188 | 1,458 |
Increase in other assets | |||||||||
-11,435 | 11,814 | -20,194 | 9,708 | -127 | -2,847 | -2,204 | 1,537 | -1,710 | 6,250 |
Increase in other liabilities | |||||||||
-292 | 15,651 | -22,195 | 16,008 | 8,192 | 7,022 | 4,787 | 1,127 | 797 | 9,923 |
Net cash provided by operating activities | |||||||||
- | - | - | - | - | 56,851 | 57,263 | - | - | - |
Net cash provided by operating activities | |||||||||
58,872 | 56,779 | 37,219 | 28,006 | 48,905 | - | - | 45,459 | 47,223 | 27,798 |
Cash flows from investing activities: | |||||||||
Net decrease (increase) in loans receivable | |||||||||
-184,586 | -96,155 | 366,559 | 273,846 | 251,699 | 229,186 | 291,494 | 328,070 | 178,307 | 209,367 |
Purchase of mortgage loans | |||||||||
138,523 | 69,227 | 65,925 | - | - | - | - | - | - | - |
Purchase of mortgage loans | |||||||||
- | - | - | 98,845 | 0 | 0 | - | 2,000 | 12,548 | 34,445 |
Proceeds from sale of loans receivable | |||||||||
8,060 | 0 | 0 | - | - | - | - | - | - | - |
Purchase of debt securities available for sale | |||||||||
0 | 0 | 66,222 | - | - | - | - | - | - | - |
Proceeds from sale of mortgage loans | |||||||||
- | - | - | - | - | - | 4,147 | - | - | 4,000 |
Proceeds from sale of mortgage loans | |||||||||
- | - | - | - | - | - | - | 416 | 0 | - |
Purchase of securities available for sale | |||||||||
- | - | - | 42,213 | 0 | 180,680 | 0 | 155,576 | 739,509 | 443,246 |
Purchase of debt securities held to maturity | |||||||||
68,106 | 144,959 | 110,664 | 82,591 | 99,289 | 3,116 | 10,629 | 5,158 | 8,334 | - |
Purchase of Federal Home Loan Bank stock | |||||||||
21,440 | 43,858 | 69,224 | 54,442 | 42,786 | - | - | - | - | - |
Principal payments on mortgage-backed securities held to maturity | |||||||||
- | - | - | - | - | - | - | - | - | 42,737 |
Principal payments on mortgage-backed securities available for sale | |||||||||
- | - | - | - | - | - | - | - | - | 49,170 |
Proceeds from payments, calls and maturities of debt securities available for sale | |||||||||
11,118 | 22,350 | 51,573 | 59,188 | 84,804 | 94,221 | 175,673 | - | - | 230,640 |
Proceeds from payments, calls and maturities of debt securities held to maturity | |||||||||
70,216 | 48,247 | 36,561 | 22,010 | 20,291 | 3,653 | 4,806 | - | - | - |
Proceeds | |||||||||
0 | 29,505 | 55,093 | - | - | - | - | - | - | - |
Proceeds from redemption of Federal Home Loan Bank stock | |||||||||
25,880 | 45,997 | 74,723 | 56,337 | 51,934 | - | - | - | - | - |
Proceeds from payments, calls and maturities of securities available for sale | |||||||||
- | - | - | - | - | - | - | -254,331 | -397,076 | - |
Proceeds from payments, calls and maturities of securities held to maturity | |||||||||
- | - | - | - | - | - | - | -6,575 | -27,156 | - |
Proceeds from sales of mortgage-backed securities held to maturity | |||||||||
- | - | - | - | - | - | - | - | - | 9,361 |
Proceeds from the sale of mortgage-backed securities available for sale | |||||||||
- | - | - | - | - | - | - | - | - | 6,087 |
Proceeds from sales of securities available for sale | |||||||||
- | - | - | 100,468 | 37,912 | 18,129 | 0 | 0 | 181,049 | 1,000 |
Proceeds from sales of debt securities held to maturity | |||||||||
0 | 0 | 1,995 | 0 | 3,375 | 8,938 | 0 | - | - | - |
Purchase of Bank Owned Life Insurance | |||||||||
- | - | - | - | 20,000 | 6,040 | 14,100 | - | - | - |
Proceeds from sales of securities held to maturity | |||||||||
- | - | - | - | - | - | - | 0 | 10,176 | - |
Purchase of Bank Owned Life Insurance | |||||||||
- | - | - | - | - | - | - | 0 | 12,950 | - |
Proceeds from BOLI benefit | |||||||||
- | - | - | - | - | - | 2,168 | 0 | 0 | - |
Proceeds from sale of real estate owned | |||||||||
1,783 | 138 | 132 | - | - | - | - | - | - | - |
Purchase of mortgage-backed securities available for sale | |||||||||
- | - | - | - | - | - | - | - | - | 5,106 |
Proceeds from redemption of Federal Home Loan Bank stock | |||||||||
- | - | - | - | - | 6,276 | 4,548 | 11,378 | 1,763 | -468 |
Writedown of real estate owned | |||||||||
- | - | - | - | - | - | - | -372 | -1,703 | -437 |
Proceeds from sale of real estate owned | |||||||||
- | - | - | 3,967 | 1,363 | 1,191 | 4,416 | 3,928 | 4,349 | 1,182 |
Proceeds from sales of real estate joint ventures and real estate investments | |||||||||
0 | 0 | 25,318 | 38,614 | 11,814 | 0 | - | - | - | - |
Proceeds from sale of other assets | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Net increase in real estate held for investment | |||||||||
- | - | - | 23 | 263 | -41 | 65 | - | - | - |
Net increase in real estate held for investment | |||||||||
- | - | - | - | - | - | - | 67 | 79 | 33 |
The net (increase) decrease in real estate joint ventures during the period.. | |||||||||
0 | 0 | 155 | -648 | 170 | 1,726 | -684 | -5 | -251 | -552 |
Purchase of fixed assets | |||||||||
191 | 356 | 419 | 835 | 692 | 572 | 593 | 1,361 | 1,055 | 1,870 |
Net cash used in investing activities | |||||||||
- | - | - | - | - | -302,614 | -133,951 | - | - | - |
Proceeds from sale of other assets | |||||||||
- | - | - | - | - | - | - | 2,748 | - | - |
Proceeds from sale of other assets | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Net cash provided by investing activities | |||||||||
73,383 | -16,008 | -433,773 | -271,563 | -204,769 | - | - | -239,535 | -338,837 | -348,870 |
Cash flows from financing activities: | |||||||||
Net increase in deposits | |||||||||
8,116 | 58,650 | 596,475 | 297,266 | 381,762 | 161,272 | 29,997 | 8,396 | 91,564 | 162,116 |
Net proceeds from issuance of common stock | |||||||||
4,442 | 12,131 | 9,567 | 14,705 | 771 | 4,844 | 2,799 | 160 | 429 | 401,752 |
Purchase of treasury stock | |||||||||
28,747 | 7,834 | 1,574 | 1,593 | 22,720 | 5,533 | 1,524 | 134,308 | 9,300 | 1,231 |
Payments for purchase of restricted stock. | |||||||||
- | - | - | - | - | - | - | 19,266 | 0 | - |
Purchase of common stock for ESOP | |||||||||
- | - | - | - | - | - | - | - | - | 17,134 |
Dividends paid to shareholders | |||||||||
49,994 | 57,353 | 51,850 | 50,007 | 39,514 | 40,438 | 43,074 | 21,848 | 19,724 | 2,830 |
(Decrease) increase in advance payments by borrowers for taxes and insurance | |||||||||
438 | 673 | 2,081 | 970 | 4,340 | 299 | 589 | -2,371 | -1,786 | -2,759 |
Increase in advance payments by borrowers for taxes and insurance | |||||||||
438 | 673 | 2,081 | 970 | 4,340 | - | - | -2,371 | -1,786 | -2,759 |
Proceeds from borrowed funds | |||||||||
70,627 | 82,683 | 144,130 | 353,433 | 119,180 | 298,770 | 289,357 | 372,085 | 438,380 | 43,475 |
Repayment of borrowed funds | |||||||||
145,444 | 128,370 | 283,694 | 368,182 | 290,251 | 164,999 | 201,550 | 135,535 | 424,617 | 56,914 |
Payment of employee taxes withheld from shared-based awards | |||||||||
30 | 81 | 1,574 | 1,593 | 1,506 | 1,586 | - | - | - | - |
Tax benefit from stock based compensation | |||||||||
- | - | - | - | - | - | 720 | 217 | 0 | 49 |
Net cash provided by financing activities | |||||||||
- | - | - | - | - | 252,629 | 77,314 | - | - | - |
Net increase (decrease) in cash and cash equivalents | |||||||||
- | - | - | - | - | 6,866 | - | - | - | - |
Net cash (used in) provided by financing activities | |||||||||
-140,592 | -39,501 | 413,561 | 244,999 | 152,062 | - | - | 72,272 | 78,518 | 532,042 |
Net increase (decrease) in cash and cash equivalents | |||||||||
-8,337 | 1,270 | 17,007 | - | - | - | - | - | - | - |
Net decrease in cash and cash equivalents | |||||||||
- | - | - | 1,442 | -3,802 | - | 626 | -121,804 | -213,096 | 210,970 |
Supplemental cash flow information: | |||||||||
Cash Paid During Period for [Abstract] | |||||||||
Interest | |||||||||
54,286 | 42,770 | 38,085 | 34,475 | 35,263 | - | - | - | - | - |
Interest | |||||||||
- | - | - | - | - | 30,931 | 29,969 | 33,523 | 36,445 | 42,633 |
Income taxes | |||||||||
17,543 | 22,668 | 30,103 | 27,272 | 25,224 | 22,784 | 32,451 | 22,512 | 13,440 | 12,685 |
Noncash transfer | |||||||||
Loans receivable transferred to real estate owned | |||||||||
0 | 1,564 | 0 | 317 | - | - | - | - | - | - |
Loans receivable transferred to real estate owned | |||||||||
- | - | - | - | 2,949 | 3,350 | 3,424 | 2,801 | 8,978 | 3,468 |
Loans transferred to other assets | |||||||||
- | - | - | - | - | - | - | - | 9,484 | - |